Health Catalyst financials
$1.75−1.13%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $311.1M | $306.6M | $295.9M | $276.2M | $241.9M | $188.8M | $154.9M |
| Gross profit | $151.7M | $140.8M | $131.8M | $133.2M | $117.6M | $90.8M | $79.6M |
| Gross margin | 48.7% | 45.9% | 44.5% | 48.2% | 48.6% | 48.1% | 51.4% |
| Operating income | -$160.9M | -$69.8M | -$126.9M | -$140.0M | -$143.7M | -$96.1M | -$54.9M |
| Net income | -$178.0M | -$69.5M | -$118.1M | -$137.4M | -$153.2M | -$115.0M | -$240.9M |
| Net margin | −57.2% | −22.7% | −39.9% | −49.7% | −63.3% | −60.9% | −155.5% |
| Diluted EPS | $-2.55 | $-1.15 | $-2.09 | $-2.63 | $-3.23 | $-2.91 | $-12.86 |
| EBITDA | -$131.0K | -$28.4M | -$84.7M | -$91.7M | -$106.1M | -$77.4M | -$45.7M |
| Operating cash flow | $731.0K | $14.6M | -$33.1M | -$35.3M | -$23.1M | -$40.2M | -$32.2M |
| Free cash flow | -$237.0K | $12.9M | -$34.3M | -$37.4M | -$33.6M | -$48.0M | -$34.2M |
| Diluted shares | 69.9M | 60.2M | 56.4M | 54.1M | 47.5M | 39.5M | 18.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $50.8M | $249.6M | $106.3M | $116.3M | $193.2M | $92.0M |
| Short-term investments | $44.9M | $142.4M | $211.5M | $247.2M | $251.8M | $178.9M |
| Total debt | $153.3M | $382.4M | $228.0M | $226.5M | $180.9M | $169.0M |
| Total assets | $502.6M | $858.9M | $701.8M | $752.3M | $832.1M | $577.7M |
| Total liabilities | $256.9M | $493.7M | $334.9M | $327.3M | $310.0M | $301.6M |
| Shareholders' equity | $245.8M | $365.2M | $366.9M | $425.0M | $522.1M | $276.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology